PharmEasy-Owned Thyrocare’s Q1 Profit Soars 34% To ₹51 Cr

PharmEasy-owned Thyrocare’s consolidated net profit for the quarter ended June 30, 2026 (Q1 FY27) zoomed 34% to ₹51.3 Cr from ₹38.3 Cr a year ago. Sequentially, profit rose 5.3% from ₹48.7 Cr. Revenue from operations jumped 24.4% to ₹240 Cr during the quarter under review from ₹193 Cr in Q1 FY26.